Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Heller

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Journal of Behavioral Medicine|June 15, 2015
Modeling predictors of changes in glycemic control and diabetes-specific quality of life amongst adults with type 1 diabetes 1 year after structured education in flexible, intensive insulin therapyDebbie Cooke, Rod Bond, Julia Lawton, et al.
The Lancet. Diabetes & Endocrinology|February 8, 2018
Technology and chronic disease management - Authors' replySudesna Chatterjee, Melanie J Davies, Simon Heller, et al.
BMC Endocrine Disorders|November 10, 2012
The 5x1 DAFNE study protocol: a cluster randomised trial comparing a standard 5 day DAFNE course delivered over 1 week against DAFNE training delivered over 1 day a week for 5 consecutive weeksJackie Elliott, Julia Lawton, David Rankin, et al.
Clinical Pharmacokinetics|June 11, 2016
Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes MellitusJulia K Mader, Lene Jensen, Steen H Ingwersen, et al.
Diabetologia|September 24, 2013
Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover studyGerd Koehler, Simon Heller, Stefan Korsatko, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 5, 2015
Investigating the Evidence of the Real-Life Impact of Acute HyperglycaemiaSimon Heller, Natalie Houwing, Nana Kragh, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|April 24, 2023
Breaking Barriers With Basal Insulin Biosimilars in Type 2 DiabetesSimon Heller, João Filipe Raposo, Santiago Tofé, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 27, 2023
Diabetes prevention at scale: Narrative review of findings and lessons from the DIPLOMA evaluation of the NHS Diabetes Prevention Programme in EnglandPeter Bower, Claudia Soiland-Reyes, Simon Heller, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mLAthena Philis-Tsimikas, Wendy Lane, Ulrik Pedersen-Bjergaard, et al.
Journal of Clinical Nursing|January 22, 2014
Type 1 diabetes patients' experiences of, and need for, social support after attending a structured education programme: a qualitative longitudinal investigationDavid Rankin, Kath Barnard, Jackie Elliott, et al.
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Journal of Behavioral Medicine|June 15, 2015
Modeling predictors of changes in glycemic control and diabetes-specific quality of life amongst adults with type 1 diabetes 1 year after structured education in flexible, intensive insulin therapyDebbie Cooke, Rod Bond, Julia Lawton, et al.
The Lancet. Diabetes & Endocrinology|February 8, 2018
Technology and chronic disease management - Authors' replySudesna Chatterjee, Melanie J Davies, Simon Heller, et al.
BMC Endocrine Disorders|November 10, 2012
The 5x1 DAFNE study protocol: a cluster randomised trial comparing a standard 5 day DAFNE course delivered over 1 week against DAFNE training delivered over 1 day a week for 5 consecutive weeksJackie Elliott, Julia Lawton, David Rankin, et al.
Clinical Pharmacokinetics|June 11, 2016
Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes MellitusJulia K Mader, Lene Jensen, Steen H Ingwersen, et al.
Diabetologia|September 24, 2013
Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover studyGerd Koehler, Simon Heller, Stefan Korsatko, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 5, 2015
Investigating the Evidence of the Real-Life Impact of Acute HyperglycaemiaSimon Heller, Natalie Houwing, Nana Kragh, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|April 24, 2023
Breaking Barriers With Basal Insulin Biosimilars in Type 2 DiabetesSimon Heller, João Filipe Raposo, Santiago Tofé, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 27, 2023
Diabetes prevention at scale: Narrative review of findings and lessons from the DIPLOMA evaluation of the NHS Diabetes Prevention Programme in EnglandPeter Bower, Claudia Soiland-Reyes, Simon Heller, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mLAthena Philis-Tsimikas, Wendy Lane, Ulrik Pedersen-Bjergaard, et al.
Journal of Clinical Nursing|January 22, 2014
Type 1 diabetes patients' experiences of, and need for, social support after attending a structured education programme: a qualitative longitudinal investigationDavid Rankin, Kath Barnard, Jackie Elliott, et al.
Pageof 16